Atıf İçin Kopyala
Pehlivan M., Nursal A., Gündeş İ., Oyacı Y., Kıvanç D., Pehlivan S.
Endocrine, metabolic & immune disorders drug targets, cilt.21, ss.925-931, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
21
-
Basım Tarihi:
2021
-
Doi Numarası:
10.2174/1871530320999200818102731
-
Dergi Adı:
Endocrine, metabolic & immune disorders drug targets
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.925-931
-
Anahtar Kelimeler:
Multiple myeloma, malignant disease, macrophage inhibitory factor, mannose binding lectin, variant, Turkish population, MIGRATION INHIBITORY FACTOR, MANNOSE-BINDING LECTIN, FACTOR GENE, PROMOTER POLYMORPHISMS, CANCER, LEUKEMIA, MIF, DIAGNOSIS, PATTERN, IMPACT
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Background: Multiple myeloma (MM) is a malignant disease manifested by the clonal proliferation of atypical plasma cells. Macrophage inhibitory factor (MIF) is one of the pleiotropic regulators in various biological and cellular processes. Mannose-binding lectin (MBL) is a crucial protein involved in the lectin pathway of the immune system.